173 related articles for article (PubMed ID: 22847457)
21. Ethanol-induced conditioned taste aversion in Warsaw Alcohol High-Preferring (WHP) and Warsaw Alcohol Low-Preferring (WLP) rats.
Dyr W; Wyszogrodzka E; Paterak J; Siwińska-Ziółkowska A; Małkowska A; Polak P
Alcohol; 2016 Mar; 51():63-9. PubMed ID: 26992702
[TBL] [Abstract][Full Text] [Related]
22. Topiramate (Topamax) reduces conditioned abstinence behaviours and handling-induced convulsions (HIC) after chronic administration of alcohol in Swiss-Webster mice.
Farook JM; Morrell DJ; Lewis B; Littleton JM; Barron S
Alcohol Alcohol; 2007; 42(4):296-300. PubMed ID: 17548369
[TBL] [Abstract][Full Text] [Related]
23. Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study.
Paparrigopoulos T; Tzavellas E; Karaiskos D; Kourlaba G; Liappas I
BMC Psychiatry; 2011 Mar; 11():41. PubMed ID: 21401921
[TBL] [Abstract][Full Text] [Related]
24. Varenicline Reduces Alcohol Intake During Repeated Cycles of Alcohol Reaccess Following Deprivation in Alcohol-Preferring (P) Rats.
Froehlich JC; Nicholson ER; Dilley JE; Filosa NJ; Rademacher LC; Smith TN
Alcohol Clin Exp Res; 2017 Aug; 41(8):1510-1517. PubMed ID: 28617959
[TBL] [Abstract][Full Text] [Related]
25. Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats.
Hargreaves GA; McGregor IS
Alcohol Clin Exp Res; 2007 Nov; 31(11):1900-7. PubMed ID: 17877781
[TBL] [Abstract][Full Text] [Related]
26. Animal model of ethanol abuse: rats selectively bred for high and low voluntary alcohol intake.
Dyr W; Kostowski W
Acta Pol Pharm; 2000 Nov; 57 Suppl():90-2. PubMed ID: 11293278
[TBL] [Abstract][Full Text] [Related]
27. Differences in the peripheral levels of beta-endorphin in response to alcohol and stress as a function of alcohol dependence and family history of alcoholism.
Dai X; Thavundayil J; Gianoulakis C
Alcohol Clin Exp Res; 2005 Nov; 29(11):1965-75. PubMed ID: 16340453
[TBL] [Abstract][Full Text] [Related]
28. Topiramate does not affect the acquisition or expression of ethanol conditioned place preference in DBA/2J or C57BL/6J mice.
Gremel CM; Gabriel KI; Cunningham CL
Alcohol Clin Exp Res; 2006 May; 30(5):783-90. PubMed ID: 16634846
[TBL] [Abstract][Full Text] [Related]
29. Glycyl-glutamine in nucleus accumbens reduces ethanol intake in alcohol preferring (P) rats.
Resch GE; Shridharani S; Millington WR; Garris DR; Simpson CW
Brain Res; 2005 Oct; 1058(1-2):73-81. PubMed ID: 16212948
[TBL] [Abstract][Full Text] [Related]
30. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
Johnson BA; Ait-Daoud N; Bowden CL; DiClemente CC; Roache JD; Lawson K; Javors MA; Ma JZ
Lancet; 2003 May; 361(9370):1677-85. PubMed ID: 12767733
[TBL] [Abstract][Full Text] [Related]
31. Topiramate reduces ethanol consumption by C57BL/6 mice.
Nguyen SA; Malcolm R; Middaugh LD
Synapse; 2007 Mar; 61(3):150-6. PubMed ID: 17146766
[TBL] [Abstract][Full Text] [Related]
32. Effects of voluntary ethanol ingestion on the POMC gene expression in the rat pituitary and on the plasma beta-endorphin content.
Winkler A; Roske I; Furkert J; Fickel J; Melzig MF
Alcohol Alcohol; 1995 Mar; 30(2):231-8. PubMed ID: 7662043
[TBL] [Abstract][Full Text] [Related]
33. Chronic ethanol tolerance as a result of free-choice drinking in alcohol-preferring rats of the WHP line.
Dyr W; Taracha E
Pharmacol Rep; 2012; 64(1):78-83. PubMed ID: 22580523
[TBL] [Abstract][Full Text] [Related]
34. The role of topiramate and other anticonvulsants in the treatment of alcohol dependence: a clinical review.
De Sousa A
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):45-9. PubMed ID: 20201814
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptides and alcohol addiction in monkeys.
van Ree JM; Kornet M; Goosen C
EXS; 1994; 71():165-74. PubMed ID: 8032147
[TBL] [Abstract][Full Text] [Related]
36. Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.
Johnson BA; Ait-Daoud N
Curr Pharm Des; 2010; 16(19):2103-12. PubMed ID: 20482511
[TBL] [Abstract][Full Text] [Related]
37. Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism.
Gianoulakis C; Krishnan B; Thavundayil J
Arch Gen Psychiatry; 1996 Mar; 53(3):250-7. PubMed ID: 8611062
[TBL] [Abstract][Full Text] [Related]
38. Effects of naltrexone plus topiramate on ethanol self-administration and tyrosine hydroxylase gene expression changes.
Navarrete F; Rubio G; Manzanares J
Addict Biol; 2014 Sep; 19(5):862-73. PubMed ID: 23573810
[TBL] [Abstract][Full Text] [Related]
39. Prazosin reduces alcohol drinking throughout prolonged treatment and blocks the initiation of drinking in rats selectively bred for high alcohol intake.
Froehlich JC; Hausauer BJ; Federoff DL; Fischer SM; Rasmussen DD
Alcohol Clin Exp Res; 2013 Sep; 37(9):1552-60. PubMed ID: 23731093
[TBL] [Abstract][Full Text] [Related]
40. Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies.
Gianoulakis C
Alcohol Alcohol; 1996 Mar; 31 Suppl 1():33-42. PubMed ID: 8736999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
